Daya Intiguna Yasa Tbk. vs Merck Tbk. — how do they compare? Daya Intiguna Yasa Tbk. trades at Rp1,005 (market cap 24.69T, 294.2K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Daya Intiguna Yasa Tbk. is far larger — about 14.5× Merck Tbk.'s market cap, and Daya Intiguna Yasa Tbk. is more actively traded (294.2K versus 37.6K). Which is the better fit depends on your goals.
| MDIY | MERK | |
|---|---|---|
Market Cap | 24.69T | 1.7T |
Volume | 294.2K | 37.6K |
Lot | 2.94K | 376 |
Turnover | 291.47M | 144.47M |
Average Price | 990.73 | 3,842.23 |
Value | 291.47M | 144.47M |
Indicative Equilibrium Price | 1,005 | 3,840 |
Indicative Equilibrium Volume | 96 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Daya Intiguna Yasa Tbk (the Company) was established based on Notarial Deed No. 7 dated 27 March 2017 of notary Drs. Bambang T Anggono Budi, S.H., M.Kn. The Company commenced its commercial operations on March 2017. The Company direct parent entity is Azara Alpina Sdn Bhd, a company incorporated and domiciled in Malaysia. The Company ultimate parent and individual entity is Mr DIY International Holding Ltd and Mr. Tan Yu Yeh, a company and individual that incorporated and domiciled in Malaysia.
Read more on MDIY →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →